Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01522248 · ClinicalTrials.gov registry record · NA
Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01522248 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 20 participants.
The verdict
NCT01522248, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Some people experience symptoms just after receiving the seasonal inactivated influenza vaccine. The cause of some of these symptoms is likely to be an immune response to the vaccine. The investigators would like to look at the earliest immune responses to the inactivated influenza vaccine. This pilot study will help us to determine at what time points we should look.
Interventions
- BIOLOGICAL Trivalent Inactivated Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01522248
The ClinicalTrials.gov registry entry for NCT01522248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trivalent Inactivated Influenza vaccine is the first listed.
NCT01522248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01522248 about?
NCT01522248 is a clinical study titled "Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study". Some people experience symptoms just after receiving the seasonal inactivated influenza vaccine. The cause of some of these symptoms is likely to be an immune response to the vaccine. The investigators would like to look at the earliest immune responses to the inactivated influenza vaccine. This pil...
What is the current status of trial NCT01522248?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-01. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01522248?
The interventions under investigation include: Trivalent Inactivated Influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01522248?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.